Advanced search
Publication Cover
Infection and Drug Resistance Volume 17, 2024 - Issue
Submit an article Journal homepage
67
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Prevalence of Hypertension and Diabetes in Severe COVID-19: A Cross-Sectional Study from Single Center, Kabul

Mohammad Zobair Wardak1 Internal Medicine Specialist, Darussalam Hospital, Kabul, AfghanistanORCID Iconhttps://orcid.org/0009-0009-7319-7258
ORCID Icon,
Ahmad Farid Daanish2 Department of Pharmacology, Kabul University of Medical Sciences, Kabul, Afghanistan
,
Ershad Ahmad Mushkani2 Department of Pharmacology, Kabul University of Medical Sciences, Kabul, AfghanistanORCID Iconhttps://orcid.org/0000-0002-1047-9137
ORCID Icon &
Mohammad Asif Atiq2 Department of Pharmacology, Kabul University of Medical Sciences, Kabul, AfghanistanCorrespondence[email protected]
Pages 1677-1683 | Received 21 Nov 2023, Accepted 23 Apr 2024, Published online: 30 Apr 2024

References

  • Yang J, Zheng YA, Gou X, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Inter J Infect Dis. 2020;94:91–95. doi:10.1016/j.ijid.2020.03.017
  • Barrera FJ, Shekhar S, Wurth R, et al. Prevalence of diabetes and hypertension and their associated risks for poor outcomes in Covid-19 patients. J Endo Soc. 2020;4(9):bvaa102. doi:10.1210/jendso/bvaa102
  • Athanasios A, Daley I, Patel A, Oyesanmi O, Desai P, Frunzi J. Cerebrovascular Accident and SARS-CoV-19 (COVID-19): a Systematic Review. Eur Neurol. 2021;84(6):418–425. doi:10.1159/000517403
  • Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323(20):2052–2059. doi:10.1001/jama.2020.6775
  • Chen X, Zheng L, Ye S, et al. Research on influencing factors and classification of patients with mild and severe COVID-19 symptoms. Front Cell Infect Microbiol. 2021;11:670823. doi:10.3389/fcimb.2021.670823
  • Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720. doi:10.1056/NEJMoa2002032
  • Afghanistan Health Survey (AHS). RMNCAH Directorate MoPH; 2019. Available from: https://rmncah-moph.gov.af/blog/2019/03/02/ahs-2018/. Accessed April 23, 2024.
  • Jin S, An H, Zhou T, et al. Age cohorts stratified according to age-distributions of COVID-19 morbidity statistics identify uniquely age-dependent CD3+ CD8+ T-cell lymphocytopenia in COVID-19 patients without comorbidities on admission. Aging. 2021;13(6):7713. doi:10.18632/aging.202691
  • Herrera-Esposito D, de Los Campos G. Age-specific rate of severe and critical SARS-CoV-2 infections estimated with multi-country seroprevalence studies. BMC Infect Dis. 2022;22(1):311. doi:10.1186/s12879-022-07262-0
  • Peng M, He J, Xue Y, Yang X, Liu S, Gong Z. Role of Hypertension on the Severity of COVID-19: a Review. J Cardiovasc Pharmacol. 2021;78(5):e648–e655. doi:10.1097/FJC.0000000000001116
  • Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama. 2020;323(11):1061–1069. doi:10.1001/jama.2020.1585
  • Guo T, Shen Q, Guo W, et al. Clinical characteristics of elderly patients with COVID-19 in Hunan Province, China: a multicenter, retrospective study. Gerontology. 2020;66(5):467–475. doi:10.1159/000508734
  • Saeed KM. Burden of hypertension in the Capital of Afghanistan: a cross-sectional study in Kabul City, 2015. Int J Hyperten. 2017;2017:3. doi:10.1155/2017/3483872
  • Neupane D, McLachlan CS, Sharma R, et al. Prevalence of hypertension in member countries of South Asian Association for Regional Cooperation (SAARC): systematic review and meta-analysis. Medicine. 2014;93(13):e74. doi:10.1097/MD.0000000000000074
  • Huang S, Wang J, Liu F, et al. COVID-19 patients with hypertension have more severe disease: a multicenter retrospective observational study. Hypertens Res. 2020;43(8):824–831. doi:10.1038/s41440-020-0485-2
  • Li R, Shen M, Yang Q, et al. Global diabetes prevalence in COVID-19 patients and contribution to COVID-19–related severity and mortality: a systematic review and meta-analysis. Diabetes Care. 2023;46(4):890–897. doi:10.2337/dc22-1943
  • Saeed KM, Asghar RJ, Sahak MN, Ansari J. Prevalence and risk factors associated with diabetes mellitus among Kabul citizens—Afghanistan, 2012. Int J Diabetes Dev Countr. 2015;35:297–303. doi:10.1007/s13410-014-0270-3
  • Colosia AD, Palencia R. Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review. Diabetes Metabol Syndr Obes. 2013;17:327–338. doi:10.2147/DMSO.S51325
  • Keel S, Foreman J, Xie J, Van Wijngaarden P, Taylor HR, Dirani M. The prevalence of self-reported diabetes in the Australian national eye health survey. PLoS One. 2017;12(1):e0169211. doi:10.1371/journal.pone.0169211
  • Li HL, Fang J, Zhao LG, et al. Personal characteristics effects on validation of self-reported type 2 diabetes from a cross-sectional survey among Chinese adults. J Epidemiol. 2020;30(11):516–521. doi:10.2188/jea.JE20190178

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.